Analysen zu Novo Nordisk
| 06.11.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 06.11.25 | Novo Nordisk Neutral | UBS AG | |
| 05.11.25 | Novo Nordisk Outperform | Bernstein Research | |
| 05.11.25 | Novo Nordisk Neutral | UBS AG | |
| 05.11.25 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 05.11.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 04.11.25 | Novo Nordisk Outperform | Bernstein Research | |
| 31.10.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 31.10.25 | Novo Nordisk Outperform | Bernstein Research | |
| 27.10.25 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 22.10.25 | Novo Nordisk Neutral | UBS AG | |
| 22.10.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 22.10.25 | Novo Nordisk Outperform | Bernstein Research | |
| 20.10.25 | Novo Nordisk Outperform | Bernstein Research | |
| 17.10.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 17.10.25 | Novo Nordisk Outperform | Bernstein Research | |
| 13.10.25 | Novo Nordisk Neutral | UBS AG | |
| 10.10.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 09.10.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 06.10.25 | Novo Nordisk Neutral | UBS AG | |
| 06.10.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 03.10.25 | Novo Nordisk Neutral | UBS AG | |
| 01.10.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 30.09.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 22.09.25 | Novo Nordisk Neutral | UBS AG | |
| 19.09.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 18.09.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 18.09.25 | Novo Nordisk Neutral | UBS AG | |
| 18.09.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 17.09.25 | Novo Nordisk Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 16.09.25 | Novo Nordisk Neutral | UBS AG | |
| 15.09.25 | Novo Nordisk Neutral | UBS AG | |
| 11.09.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 10.09.25 | Novo Nordisk Outperform | Bernstein Research | |
| 10.09.25 | Novo Nordisk Neutral | UBS AG | |
| 10.09.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 08.09.25 | Novo Nordisk Neutral | UBS AG | |
| 05.09.25 | Novo Nordisk Neutral | UBS AG | |
| 04.09.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 01.09.25 | Novo Nordisk Neutral | UBS AG | |
| 29.08.25 | Novo Nordisk Neutral | UBS AG | |
| 27.08.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 26.08.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 21.08.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 19.08.25 | Novo Nordisk Neutral | UBS AG | |
| 18.08.25 | Novo Nordisk Neutral | UBS AG | |
| 12.08.25 | Novo Nordisk Neutral | UBS AG | |
| 11.08.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 08.08.25 | Novo Nordisk Neutral | UBS AG | |
| 08.08.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. |
Aktuelle Aktienanalysen
| 24.04.26 | Saint-Gobain Neutral | Goldman Sachs Group Inc. | |
| 24.04.26 | Siemens Energy Buy | Goldman Sachs Group Inc. | |
| 24.04.26 | SAP Buy | Goldman Sachs Group Inc. | |
| 24.04.26 | Siemens Energy Buy | Jefferies & Company Inc. | |
| 24.04.26 | EssilorLuxottica Overweight | Barclays Capital | |
| 24.04.26 | STMicroelectronics Underweight | Barclays Capital | |
| 24.04.26 | Intel Hold | Jefferies & Company Inc. | |
| 24.04.26 | Intel Underweight | JP Morgan Chase & Co. | |
| 24.04.26 | STMicroelectronics Buy | Jefferies & Company Inc. | |
| 24.04.26 | Vossloh Hold | Jefferies & Company Inc. | |
| 24.04.26 | SAP Neutral | JP Morgan Chase & Co. | |
| 24.04.26 | SAP Buy | Jefferies & Company Inc. | |
| 23.04.26 | Saint-Gobain Buy | Jefferies & Company Inc. | |
| 23.04.26 | L'Oréal Outperform | RBC Capital Markets | |
| 23.04.26 | Siemens Energy Outperform | Bernstein Research | |
| 23.04.26 | Adyen B.V. Parts Sociales Overweight | JP Morgan Chase & Co. | |
| 23.04.26 | Valeo Overweight | JP Morgan Chase & Co. | |
| 23.04.26 | VINCI Outperform | RBC Capital Markets | |
| 23.04.26 | Saint-Gobain Buy | Jefferies & Company Inc. | |
| 23.04.26 | Siemens Energy Outperform | RBC Capital Markets | |
| 23.04.26 | Siemens Energy Overweight | JP Morgan Chase & Co. | |
| 23.04.26 | RENK Buy | Jefferies & Company Inc. | |
| 23.04.26 | Nestlé Sector Perform | RBC Capital Markets | |
| 23.04.26 | EssilorLuxottica Kaufen | DZ BANK | |
| 23.04.26 | Apple Neutral | UBS AG | |
| 23.04.26 | L'Oréal Kaufen | DZ BANK | |
| 23.04.26 | Lufthansa Halten | DZ BANK | |
| 23.04.26 | Tesla Neutral | UBS AG | |
| 23.04.26 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 23.04.26 | STMicroelectronics Underweight | Barclays Capital | |
| 23.04.26 | Nokia Underweight | Barclays Capital | |
| 23.04.26 | Sartorius Stedim Biotech Overweight | Barclays Capital | |
| 23.04.26 | Nestlé Equal Weight | Barclays Capital | |
| 23.04.26 | Sartorius vz. Overweight | Barclays Capital | |
| 23.04.26 | Sanofi Equal Weight | Barclays Capital | |
| 23.04.26 | Tesla Equal Weight | Barclays Capital | |
| 23.04.26 | Symrise Equal Weight | Barclays Capital | |
| 23.04.26 | ASML NV Outperform | Bernstein Research | |
| 23.04.26 | HSBC Holdings Overweight | Barclays Capital | |
| 23.04.26 | L'Oréal Overweight | Barclays Capital | |
| 23.04.26 | Allianz Sector Perform | RBC Capital Markets | |
| 23.04.26 | Tesla Halten | DZ BANK | |
| 23.04.26 | Sartorius vz. Buy | Jefferies & Company Inc. | |
| 23.04.26 | Douglas Buy | Jefferies & Company Inc. | |
| 23.04.26 | Scout24 Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 23.04.26 | ASOS Buy | Deutsche Bank AG | |
| 23.04.26 | ASML NV Buy | UBS AG | |
| 23.04.26 | STMicroelectronics Buy | UBS AG | |
| 23.04.26 | ASOS Neutral | JP Morgan Chase & Co. | |
| 23.04.26 | Roche Underperform | Jefferies & Company Inc. |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.